1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Investor Presentation March 2026
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
TELA Bio Enters $70 Million Perceptive Term Loan Facility
Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
Board Expansion - William Plovanic Appointed as Class I Director
Changes in Board, Management or Compensation
Reports Second Quarter 2025 Financial Results
Appoints Jeffrey Blizard as President
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report